Cardiac medical device shows promise in clinical trial
Sunshine Heart's cardiac medical device, the C-Pulse, has shown promise in a clinical trial, and the company plans to apply for pre-market approval sometime in the fourth quarter.
Medtronic announced today that the FDA approved an expanded indication for its cardiac resynchronization therapy with implantable cardioverter defibrillator devices.